WE measured sIL-2R, TNF-and slCAM-1 in the Detection of soluble interleukin-2 sera and middle ear effusions (MEEs) of patients with otitis media with effusion (OME). Although receptor and soluble intercellular there was no signmcant difference between the adhesion molecule-1 in the effusion sIL-2R levels of the serous and mucoid MEEs, they were significantly higher than serum of otitis media with effusion levels of OME patients and healthy controls. TNFlevels of the mucoid MEEs were significantly higher than those of the serous type. However, TNF-was rarely detected in the sera of OME T. Ganbo 
Introduction
submucosa of the middle ears. 18'19 Cytokines form a network together with inflammatory cells Interleukin-2 (IL-2) is one of the most well and adhesion molecules, and play important characterized cytokines. It stimulates the proroles in the inflammatory disorders. It is necesliferation of activated T-lymphocytes, 1'2 and binds sal T to investigate the effects of cytokines and to the IL-2 receptor (IL-2R) which is composed adhesion molecules on the pathogenesis of OME. of three distinct subunits, namely a, [3 and T. However, there have been few reports about slLchains. [3] [4] [5] In patients with rheumatoid arthritis, 6 2R and slCAM-1 in cases with OME. Therefore, adult T cell leukaemia, 7 Kawasaki disease 8 and we studied slL-2R, TNF-a and slCAM-1 in the bronchial asthma, 9 the serum levels of soluble ILmiddle ear effusion and the sera of patients with 2R (slL-2R), which is the released extracellular OME.
domain of the a-chain of IL-2R, are elevated.
Moreover, activated T-lymphocytes are reported not only to elaborate interferon-gamma (INF-T)
Materials and Methods and to cause macrophages to produce turnout necrosis factor-alpha (TNF-a), 11 
Results
The levels of sIL-2R in the MEEs and sera are illustrated in Fig. 1 . The mean level of sIL-2R in the mucoid MEEs was 15000U/ml, while the mean level in the serous MEEs was 9500 U/ml.
There was no significant difference between the slL-2R levels of the two types of MEEs. However, the slL-2R levels in both types were significantly higher than those of the sera of OME patients, which was 326U/ml on the average. Moreover, there was no significant difference between the sera of OME patients and those of the healthy controls (310 U/ml).
The levels of TNF<z in the MEEs and sera are illustrated in Fig. 2 . The mean level of TNF-z in the mucoid MEEs was 300pg/ml, whereas the The levels of slCAM-1 in the MEEs and sera are illustrated in Fig. 3 . The mean level of sICAM-1 in the mucoid MEEs was 1440 ng/ml, whereas the mean level in the serous MEEs was 430 ng/ ml. Thus, a significant difference was observed between slCAM-1 levels of the two types of MEEs. Furthermore, the levels of slCAM-1 in the two types of MEEs were significantly different from those of the sera of the OME patients because the mean serum level was 180ng/ml. However, there was no significant difference between the sera of the OME patients and those of the healthy controls (180 ng/ml).
Discussion
The slL-2R levels in the serous and mucoid types of MEEs were high, their mean values being 9500 U/ml and 15 000 U/ml, respectively. These values were extremely high as compared with the sIL-2R levels of bronchoalveolar lavage fluid (BALF) of asthma (42U/ml) and miliary tuberculosis (1320U/ml), 9 nasal secretion of nasal allergy (1510 U/ml) 2 and synovial effusion of rheumatoid arthritis (1170 U/ml). 6 Even in the severe cases of acute asthma, 22 extensive pulmonary tuberculosis 2 and acute-phase Kawasaki disease, s it was reported that the mean values of serum slL-2R levels were about 570 U/ml, 2700 U/ ml and 3700 U/ml, respectively. However, slL-2R level of acute adult T cell leukaemia which was beyond 10000 U/ml in serum, 7 was as high as that of MEE. In our study, the mean level of slL-2R in the sera of OME patients was 326 U/ml, which was the same as that of the healthy controis (310U/ml). These data suggest that the expression of IL-2R on activated T lymphocytes and the binding of IL-2 to its receptor might be concerned with local pathogenesis of OME in the middle ear. Yellon et a/. 24 also reported that IL-2 was detected in the MEEs of 54% of OME patients. However, there is a possibility that IL-2 might be biologically a little unstable or technically difficult to detect as compared with slL-2R, because slL-2R was detectable in all our cases.
There are a few reports which claim that TNFcz was detected in the MEEs of OME, [24] [25] [26] although its values were expressed with the unit of pg/mg of total protein. Particularly, the mucoid type effusion is too viscous to dissolve in PBS. In our methods, we used dithiothreitol and liquefied the mucoid pellet to dissolve it in PBS. 2 We expressed TNF<z levels in the effusion with the unit of pg/ml and could compare TNF<z values with those of other diseases. In the BAIs 27 and sputa 28 of patients with active asthma, mean TNF-z levels were 578 pg/ml and 1783 pg/ml, respectively. In children with leukaemia, the mean level of TNF-cz in the sera was 63.6pg/ml while it was 21.5 pg/ml in the solid tumours. 29 We found that the mean TNF-z level in the mucoid type effusions was similar to that in BALFs of asthma patients.
Chihara et al. reported that slCAM-1 levels of sputa and sera of asthma patients were 8.6 ng/ml and 350ng/ml, respectively, and that the slCAM-1 level in the normal human sera was 200 ng/ml. It means that the mean serum level of slCAM-1 in asthma was 1.75 times higher than that in the healthy control and that its sputum level could be disregarded as it was too low as compared with the serum level of control subjects. In our study, slCAM-1 levels in the serous and mucoid MEEs were 5.3 and 7.8 times higher than those in the control sera. slCAM-1 levels in various other diseases have also been reported. In patients with rheumatoid arthritis, serum and synovial fluid levels of slCAM-1 were 1.2 and 1.5 times higher than the serum levels of the normal controls, respectively. Serum levels of sICAM-1 in patients with nasal allergy 32 4 These inflammatory cells invade the middle ear of OME patients. In cases of serous types of OME, it was reported that a larger number of neutrophils and lymphocytes were observed in the MEEs and that more severe inflammatory signs were shown in the submucosa, as compared with mucoid types. 18 '19 However, particularity in our study, slCAM-1 levels of mucoid MEEs were significantly higher than those of serous MEEs. These morphological findings of cellular infiltration, which might be induced by ICAM-1, disagreed with slCAM-1 levels detected in the MEEs. Therefore, it is necessary to investigate the more detailed roles of slL-2R and slCAM-1 in the pathogenesis of OME.
It has been reported that various chemical mediators such as leukotrienes, prostaglandins 5 and platelet activating factor were detectable in the MEEs of OME. These chemical mediators are responsible at least partly for the pathogenesis of OME because they could induce hypersecretion and inhibit mucociliary transport systems in the middle ear, causing an accumulation of the effusion. v' However, these mediators could also be secreted by inflammatory cells that infiltrated into the focus. Furthermore, these inflammatory cells are regulated by the cytokine network that consists of cytokines and related factors. Our investigation indicated the possibility that IL-2, TNF<z and ICAM-1 could affect the pathogenesis of OME through the inflammatory cells and the chemical mediators derived from these cells.
